These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 14404740)

  • 1. An antagonism between 3-4 dioxyphenylalanine (DOPA) and 5-hydroxytryptophan (5-HTP).
    KATO R
    Experientia; 1959 Nov; 15():424-5. PubMed ID: 14404740
    [No Abstract]   [Full Text] [Related]  

  • 2. 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.
    CARLSSON A; LINDQVIST M; MAGNUSSON T
    Nature; 1957 Nov; 180(4596):1200. PubMed ID: 13483658
    [No Abstract]   [Full Text] [Related]  

  • 3. L-3,4-dihydroxyphenylalanine and L-5-hydroxytryptophan share the same transporter in Opossum kidney cells.
    Gomes P; Serrão MP; Vieira-Coelho MA; Soares-da-Silva P
    Int J Biochem Cell Biol; 1998 Feb; 30(2):243-50. PubMed ID: 9608678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of D-5-hydroxytryptophan and D-DOPA on binding at serotonin and dopamine receptors.
    Acton G
    Res Commun Chem Pathol Pharmacol; 1988 Apr; 60(1):129-32. PubMed ID: 3132733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
    Roberge AG; Poirier LJ
    Brain Res; 1974 Aug; 76(3):401-12. PubMed ID: 4546739
    [No Abstract]   [Full Text] [Related]  

  • 6. [EXPERIMENTAL ANTAGONISM OF CHLORPROMAZINE AND THIORIDAZINE IN RELATION TO CERTAIN EFFECTS OF LYSERGIDE].
    NAKAJIMA H; GRANDJEAN JL; LHUILLIER J; THUILLIER J
    Encephale; 1964; 53():SUPPL:131-41. PubMed ID: 14161525
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of 5-hydroxytryptophan nephrotoxicity by alpha-difluoromethyl-dopa, an inhibitor or L-amino acid decarboxylase.
    Zbinden G; Brändle E
    Toxicol Lett; 1980 Feb; 5(2):125-9. PubMed ID: 6781106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. THE EFFECT OF L-3, 4-DIHYDROXYPHENYLALANINE AND DL-5-HYDROXYTRYPTOPHAN ON RIGIDITY AND TREMOR INDUCED BY RESERPINE, CHLORPROMAZINE AND PHENOXYBENZAMINE.
    ROOS BE; STEG G
    Life Sci (1962); 1964 Apr; 3():351-60. PubMed ID: 14172950
    [No Abstract]   [Full Text] [Related]  

  • 9. Relation of dopa and 5-HTP to convulsions induced by strychnine and leptazol.
    Bennett JM
    Eur J Pharmacol; 1970 Jan; 9(1):27-30. PubMed ID: 4313984
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sleep and monoamines: differential radioautography of central neurons after systematic injection of tritiated 5-hydroxytryptophane (5 HTP 3H) or of dihydroxyphenylalanine (DOPA 3H)].
    Petitjean F; Buda C; Janin M; Touret M; Salvert D; Jouvet M; Bobillier P
    C R Acad Hebd Seances Acad Sci D; 1978 Nov; 287(12):1135-9. PubMed ID: 157232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of locomotor suppressant effects of reserpine in mice.
    SMITH CB; DEWS PB
    Psychopharmacologia; 1962 Mar; 3():55-9. PubMed ID: 13914163
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
    Koopmans KP; Neels OC; Kema IP; Elsinga PH; Sluiter WJ; Vanghillewe K; Brouwers AH; Jager PL; de Vries EG
    J Clin Oncol; 2008 Mar; 26(9):1489-95. PubMed ID: 18349401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of DOPA and 5-HTP on rhythmic efferent discharges in hind limb nerves in the rabbit.
    Viala D; Buser P
    Brain Res; 1969 Feb; 12(2):437-43. PubMed ID: 5306638
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the uptake of radiolabeled DOPA, 5-HTP and tryptophan in rat tissues in vivo: effect of methionine, tryptophan and some keto acids.
    Shah NS; Kamano A; Glisson S; Callison D
    Int J Neuropharmacol; 1968 Mar; 7(2):75-86. PubMed ID: 5304560
    [No Abstract]   [Full Text] [Related]  

  • 15. [EFFECTS OF RESERPINE, DOPA AND 5-HTP ON THE 2 SLEEP STATES].
    MATSUMOTO J; JOUVET M
    C R Seances Soc Biol Fil; 1964; 158():2137-40. PubMed ID: 14282133
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8beta-carbobenzyloxy-aminomethyl-10alpha-ergoline. Interference with amphetamine and DOPA.
    Ferrini R; Glässer A
    Psychopharmacologia; 1965 Nov; 8(4):271-6. PubMed ID: 5296119
    [No Abstract]   [Full Text] [Related]  

  • 17. [5-HYDROXYTRYPTOPHAN DOPA DECARBOXYLASE IN NERVOUS AND CARDIAC TISSUES IN THE MOLLUSC HELIX POMATIA. INTERACTION OF SUBSTRATES IN VITRO].
    CARDOT J
    C R Hebd Seances Acad Sci; 1964 Jul; 259():902-4. PubMed ID: 14190531
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

  • 19. The sedative and lethal actions of reserpine in mice, as modified by 5-hydroxytryptophan, 3,4-dihydroxyphenylalanine, methylphenidate, and nikethamide in cold and warm environments.
    AIRAKSINEN MM; MATTILA M
    Acta Pharmacol Toxicol (Copenh); 1962; 19():199-204. PubMed ID: 14011421
    [No Abstract]   [Full Text] [Related]  

  • 20. The administration of BAS, 5-HTP, and marsilid to schizophrenic patients.
    FELDSTEIN A; FREEMAN H; HOPE JM; DIBNER IM; HOAGLAND H
    Am J Psychiatry; 1959 Sep; 116():219-21. PubMed ID: 13822063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.